Optogenetic recruitment of hypothalamic corticotrophin-releasing-hormone (CRH) neurons reduces motivational drive.

Caitlin S Mitchell, Erin J Campbell, Simon D Fisher, Laura M Stanton, Nicholas J Burton, Amy J Pearl, Gavan P McNally, Jaideep S Bains, Tamás Füzesi, Brett A Graham, Elizabeth E Manning, Christopher V Dayas
Author Information
  1. Caitlin S Mitchell: School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, NSW, 2308, Australia.
  2. Erin J Campbell: School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, NSW, 2308, Australia.
  3. Simon D Fisher: School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, NSW, 2308, Australia.
  4. Laura M Stanton: School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, NSW, 2308, Australia. ORCID
  5. Nicholas J Burton: School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, NSW, 2308, Australia.
  6. Amy J Pearl: School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, NSW, 2308, Australia.
  7. Gavan P McNally: School of Psychology, University of New South Wales, UNSW, Sydney, NSW, 2052, Australia. ORCID
  8. Jaideep S Bains: Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
  9. Tamás Füzesi: Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada. ORCID
  10. Brett A Graham: School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, NSW, 2308, Australia.
  11. Elizabeth E Manning: School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, NSW, 2308, Australia. lizzie.manning@newcastle.edu.au. ORCID
  12. Christopher V Dayas: School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, NSW, 2308, Australia. christopher.dayas@newcastle.edu.au.

Abstract

Impaired motivational drive is a key feature of depression. Chronic stress is a known antecedent to the development of depression in humans and depressive-like states in animals. Whilst there is a clear relationship between stress and motivational drive, the mechanisms underpinning this association remain unclear. One hypothesis is that the endocrine system, via corticotropin-releasing hormone (CRH) in the paraventricular nucleus of the hypothalamus (PVN; PVN), initiates a hormonal cascade resulting in glucocorticoid release, and that excessive glucocorticoids change brain circuit function to produce depression-related symptoms. Another mostly unexplored hypothesis is that the direct activity of PVN neurons and their input to other stress- and reward-related brain regions drives these behaviors. To further understand the direct involvement of PVN neurons in motivation, we used optogenetic stimulation to activate these neurons 1 h/day for 5 consecutive days and showed increased acute stress-related behaviors and long-lasting deficits in the motivational drive for sucrose. This was associated with increased Fos-protein expression in the lateral hypothalamus (LH). Direct stimulation of the PVN inputs in the LH produced a similar pattern of effects on sucrose motivation. Together, these data suggest that PVN neuronal activity may be directly responsible for changes in motivational drive and that these behavioral changes may, in part, be driven by PVN synaptic projections to the LH.

References

  1. Cell. 2005 Nov 4;123(3):493-505 [PMID: 16269339]
  2. Alcohol Clin Exp Res. 2008 Feb;32(2):209-21 [PMID: 18162077]
  3. Brain Res. 2011 May 19;1391:54-9 [PMID: 21439948]
  4. Lancet. 2018 Nov 10;392(10159):1789-1858 [PMID: 30496104]
  5. Cell. 2015 Jan 29;160(3):516-27 [PMID: 25635459]
  6. Neurosci Biobehav Rev. 2019 Apr;99:101-116 [PMID: 30529362]
  7. Sci Adv. 2020 Sep 9;6(37): [PMID: 32917689]
  8. J Neural Transm (Vienna). 2023 Sep;130(9):1133-1151 [PMID: 36786896]
  9. Physiol Behav. 2012 May 15;106(2):142-50 [PMID: 22330326]
  10. Neuroscience. 2007 Nov 30;150(1):8-13 [PMID: 17961928]
  11. Biol Psychiatry. 2008 Nov 15;64(10):884-90 [PMID: 18675955]
  12. Endocr Rev. 2000 Feb;21(1):55-89 [PMID: 10696570]
  13. J Neurosci Res. 2021 Sep;99(9):2046-2058 [PMID: 34048600]
  14. Expert Opin Ther Targets. 2008 Jun;12(6):717-27 [PMID: 18479218]
  15. Anesth Prog. 2013 Spring;60(1):25-31; quiz 32 [PMID: 23506281]
  16. PLoS One. 2013 May 28;8(5):e64943 [PMID: 23724107]
  17. J Neurosci. 2014 Aug 27;34(35):11560-70 [PMID: 25164654]
  18. Brain Struct Funct. 2018 Jul;223(6):2685-2698 [PMID: 29569009]
  19. Nat Neurosci. 2010 Jan;13(1):133-40 [PMID: 20023653]
  20. Psychopharmacology (Berl). 2009 Jun;204(2):361-73 [PMID: 19189082]
  21. Neuropsychobiology. 2005;52(2):90-110 [PMID: 16037678]
  22. Nat Neurosci. 2019 Apr;22(4):576-585 [PMID: 30833699]
  23. Recent Prog Horm Res. 1983;39:245-70 [PMID: 6314446]
  24. Curr Protoc Neurosci. 2009 Oct;Chapter 9:Unit 9.32 [PMID: 19802817]
  25. Brain Res. 1987 Dec 8;436(1):143-7 [PMID: 2446717]
  26. J Affect Disord. 2001 Jan;62(1-2):77-91 [PMID: 11172875]
  27. Phytomedicine. 2006 Nov;13(9-10):658-67 [PMID: 16516452]
  28. Am J Psychiatry. 1999 Jun;156(6):837-41 [PMID: 10360120]
  29. J Neurosci. 2005 Jun 1;25(22):5389-96 [PMID: 15930388]
  30. Curr Biol. 2019 Apr 1;29(7):1243-1251.e4 [PMID: 30853436]
  31. Neuron. 2011 Sep 22;71(6):995-1013 [PMID: 21943598]
  32. Psychol Med. 2006 Jun;36(6):779-88 [PMID: 16566849]
  33. Biochem Biophys Res Commun. 2002 Aug 9;296(1):129-33 [PMID: 12147238]
  34. Basic Clin Neurosci. 2014 Spring;5(2):131-7 [PMID: 25337371]
  35. Neurosci Biobehav Rev. 2001 Dec;25(7-8):669-78 [PMID: 11801292]
  36. Eur J Neurosci. 2017 Oct;46(7):2285-2296 [PMID: 28858406]
  37. Behav Res Ther. 2008 Oct;46(10):1142-50 [PMID: 18707676]
  38. Behav Brain Res. 1994 Nov 16;65(1):47-55 [PMID: 7880454]
  39. Eur J Neurosci. 2005 Jul;22(1):93-106 [PMID: 16029199]
  40. Science. 2017 Sep 29;357(6358):1406-1411 [PMID: 28963257]
  41. Psychosom Med. 2011 Feb-Mar;73(2):114-26 [PMID: 21257974]
  42. Front Pharmacol. 2018 Sep 25;9:1061 [PMID: 30319410]
  43. J Neurosci. 2011 Jul 6;31(27):9848-57 [PMID: 21734276]
  44. J Neurophysiol. 2015 Sep;114(3):1713-24 [PMID: 26180121]
  45. Epilepsy Behav. 2014 Sep;38:148-59 [PMID: 24269030]
  46. Nature. 2016 Nov 10;539(7628):289-293 [PMID: 27652894]
  47. J Comp Neurol. 1990 Jun 22;296(4):517-30 [PMID: 2113539]
  48. Science. 2013 Sep 27;341(6153):1517-21 [PMID: 24072922]
  49. Physiol Behav. 1978 Jun;20(6):709-16 [PMID: 684108]
  50. Eur J Neurosci. 2001 Oct;14(7):1143-52 [PMID: 11683906]
  51. Int J Neuropsychopharmacol. 2019 Feb 1;22(2):105-118 [PMID: 30239748]
  52. J Neurosci Methods. 2014 Aug 15;233:150-4 [PMID: 24932962]
  53. Trends Neurosci. 1997 Feb;20(2):78-84 [PMID: 9023876]
  54. Nat Neurosci. 2019 Jul;22(7):1039-1041 [PMID: 31209377]
  55. Curr Biol. 2017 Jul 24;27(14):2089-2100.e5 [PMID: 28690111]
  56. Nat Commun. 2016 Jun 16;7:11937 [PMID: 27306314]

Grants

  1. APP 1165679/Department of Health | National Health and Medical Research Council (NHMRC)
  2. APP 1165679/Department of Health | National Health and Medical Research Council (NHMRC)
  3. APP 1165679/Department of Health | National Health and Medical Research Council (NHMRC)
  4. APP 1165679/Department of Health | National Health and Medical Research Council (NHMRC)
  5. APP 1165679/Department of Health | National Health and Medical Research Council (NHMRC)
  6. APP 1165679/Department of Health | National Health and Medical Research Council (NHMRC)
  7. APP 1165679/Department of Health | National Health and Medical Research Council (NHMRC)
  8. APP 1165679/Department of Health | National Health and Medical Research Council (NHMRC)
  9. APP 1165679/Department of Health | National Health and Medical Research Council (NHMRC)
  10. APP 1165679/Department of Health | National Health and Medical Research Council (NHMRC)
  11. APP 1165679/Department of Health | National Health and Medical Research Council (NHMRC)
  12. APP 1165679/Department of Health | National Health and Medical Research Council (NHMRC)

MeSH Term

Animals
Humans
Corticotropin-Releasing Hormone
Adrenocorticotropic Hormone
Motivation
Pituitary Hormone-Releasing Hormones
Optogenetics
Hypothalamus
Glucocorticoids
Neurons
Sucrose

Chemicals

Corticotropin-Releasing Hormone
Adrenocorticotropic Hormone
Pituitary Hormone-Releasing Hormones
Glucocorticoids
Sucrose

Word Cloud

Created with Highcharts 10.0.0PVNmotivationaldriveneuronsLHdepressionstresshypothesisCRHhypothalamusbraindirectactivitybehaviorsmotivationstimulationincreasedsucrosemaychangesImpairedkeyfeatureChronicknownantecedentdevelopmenthumansdepressive-likestatesanimalsWhilstclearrelationshipmechanismsunderpinningassociationremainunclearOneendocrinesystemviacorticotropin-releasinghormoneparaventricularnucleusinitiateshormonalcascaderesultingglucocorticoidreleaseexcessiveglucocorticoidschangecircuitfunctionproducedepression-relatedsymptomsAnothermostlyunexploredinputstress-reward-relatedregionsdrivesunderstandinvolvementusedoptogeneticactivate1h/day5consecutivedaysshowedacutestress-relatedlong-lastingdeficitsassociatedFos-proteinexpressionlateralDirectinputsproducedsimilarpatterneffectsTogetherdatasuggestneuronaldirectlyresponsiblebehavioralpartdrivensynapticprojectionsOptogeneticrecruitmenthypothalamiccorticotrophin-releasing-hormonereduces

Similar Articles

Cited By